Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RANIBIZUMAB Cause Hypersensitivity? 80 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 80 reports of Hypersensitivity have been filed in association with RANIBIZUMAB (CIMERLI). This represents 0.5% of all adverse event reports for RANIBIZUMAB.

80
Reports of Hypersensitivity with RANIBIZUMAB
0.5%
of all RANIBIZUMAB reports
2
Deaths
16
Hospitalizations

How Dangerous Is Hypersensitivity From RANIBIZUMAB?

Of the 80 reports, 2 (2.5%) resulted in death, 16 (20.0%) required hospitalization, and 1 (1.3%) were considered life-threatening.

Is Hypersensitivity Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RANIBIZUMAB. However, 80 reports have been filed with the FAERS database.

What Other Side Effects Does RANIBIZUMAB Cause?

Death (2,250) Off label use (1,467) Visual acuity reduced (1,342) Visual impairment (1,185) No adverse event (1,012) Drug ineffective (831) Blindness (760) Vision blurred (711) Eye pain (632) Cerebrovascular accident (543)

What Other Drugs Cause Hypersensitivity?

ETANERCEPT (10,846) ADALIMUMAB (10,641) METHOTREXATE (9,799) TOCILIZUMAB (9,076) ABATACEPT (8,945) INFLIXIMAB (8,519) RITUXIMAB (8,408) ADAPALENE (8,356) LEFLUNOMIDE (7,926) CERTOLIZUMAB PEGOL (7,353)

Which RANIBIZUMAB Alternatives Have Lower Hypersensitivity Risk?

RANIBIZUMAB vs RANIMUSTINE RANIBIZUMAB vs RANITIDINE RANIBIZUMAB vs RANITIDINE\RANITIDINE RANIBIZUMAB vs RANOLAZINE RANIBIZUMAB vs RAPAMUNE

Related Pages

RANIBIZUMAB Full Profile All Hypersensitivity Reports All Drugs Causing Hypersensitivity RANIBIZUMAB Demographics